| 中文名稱 | 甲醇中加替沙星溶液標(biāo)準(zhǔn)物質(zhì) |
| 分子量 | 375.39 |
| CAS號(hào) | 112811-59-3 |
| 產(chǎn)品性狀 | |
| 中文別名 | 加替沙星;1-環(huán)丙基-6-氟-1,4-二氫-8-甲氧基-7-(3-甲基-1-哌嗪基)-4-氧代-3-喹啉羧酸;1-環(huán)丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氫-4-氧-喹啉-3-羧酸;加替沙星片;4-甲基-3-硝基苯硼酸頻哪醇酯;加替沙星 標(biāo)準(zhǔn)品;加替沙星雜質(zhì);金陽堿;加替沙星,鹽酸D4;加替沙星·3;加替沙星(標(biāo)準(zhǔn)品);加替沙星溶液,100PPM;加替沙星/1-環(huán)丙基-6-氟-7 -(3-甲基哌嗪-1-基)-8-甲氧基-1,4-二氫-4-氧-喹啉-3-羧酸;優(yōu)質(zhì)高純度，加替沙星原粉 |
| 質(zhì)量指標(biāo) | |
| 英文名稱 | |
| 產(chǎn)品特性 | |
| 英文別名 | 1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid;GATIFLOXACIN;1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-8-METHOXY-7-(3-METHYLPIPERAZIN-1-YL)-4-OXO-3-QUINOLINECARBOXYLIC ACID;1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDROXY-8-METHOXY-7-(3-METHYL-1-PIPERAZINYL)-4-OXO-3-QUINOLINECARBOXYLIC ACID;1-CYCLOPROPYL-6-FLUORO-8-METHOXY-7-(3-METHYL-PIPERAZIN-1-YL)-4-OXO-1,4-DIHYDRO-QUINOLINE-3-CARBOXYLIC ACID;AKOS NCG1-0010;TEQUIN;Gatifloxacin(AM-1155);Gatifloxacin n-Hydrate;1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid);2H2O;AM 1155;AM-1155;BMS 206584-01;PD 135432;PD-135432;Zymar;CG5501;Gatiquin;BMS-206584;GASTRODINUM;Gatifloxacin API;Gatifloxacin 1.5H20;Gatiflo;Gatifloxacine;Gatispan;Zymaxid;Gatilox;Gaity;CG 5501;Gatifloxacin [USAN:INN];gatifloxacin anhydrous;gatifloxacinum;gatifloxacino;1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo;Gatifloxacin hydrate;1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-o |
| 應(yīng)用領(lǐng)域 | |
| EINEC號(hào) | |
| 包裝規(guī)格 | 1000μg/mL | 1.2mL |
| 分子式 | C19H22FN3O4 |
| 儲(chǔ)存方法 |
